Globally, One in 13 Youth Experience Nocturnal Enuresis
By Lori Solomon HealthDay Reporter
TUESDAY, April 8, 2025 -- One in 13 youth and adolescents globally experience nocturnal enuresis, according to a review published online March 20 in Child and Adolescent Psychiatry and Mental Health.
Molalign Aligaz Adisu, from the College of Health Sciences at Woldia University in Ethiopia, and colleagues conducted a systematic literature review and meta-analysis seeking to synthesize global epidemiological data on nocturnal enuresis.
Based on 128 studies (445,242 individuals in 39 countries), the researchers found that the overall pooled prevalence of nocturnal enuresis among children and adolescents was 7.2 percent. Factors significantly associated with nocturnal enuresis included a positive family history (adjusted odds ratio [aOR], 1.49), positive urinary tract infection (aOR, 3.89), parental death (aOR, 1.93), first birth order (aOR, 0.5), and male sex (aOR 1.63).
"It is recommended that health care providers should implement routine screening for nocturnal enuresis, particularly for children with known risk factors such as family history and urinary tract infections, and the development of targeted interventions and support mechanisms should be prioritized, considering the significant impacts of these factors among children and adolescents," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.